Immunic to participate in scientific and investor conferences in october

New york , oct. 1, 2025 /prnewswire/ --  immunic, inc.  (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following scientific and investor conferences in october: october 4-7: uegw 2025 – united european gastroenterology week. immunic's r&d team will attend this conference in berlin, germany.
IMUX Ratings Summary
IMUX Quant Ranking